Cargando…

Analysis of Epithelial and Mesenchymal Markers in Ovarian Cancer Reveals Phenotypic Heterogeneity and Plasticity

In our studies of ovarian cancer cells we have identified subpopulations of cells that are in a transitory E/M hybrid stage, i.e. cells that simultaneously express epithelial and mesenchymal markers. E/M cells are not homogenous but, in vitro and in vivo, contain subsets that can be distinguished ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Strauss, Robert, Li, Zong-Yi, Liu, Ying, Beyer, Ines, Persson, Jonas, Sova, Pavel, Möller, Thomas, Pesonen, Sari, Hemminki, Akseli, Hamerlik, Petra, Drescher, Charles, Urban, Nicole, Bartek, Jiri, Lieber, André
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021543/ https://www.ncbi.nlm.nih.gov/pubmed/21264259 http://dx.doi.org/10.1371/journal.pone.0016186

Ejemplares similares

Correction: Analysis of Epithelial and Mesenchymal Markers in Ovarian Cancer Reveals Phenotypic Heterogeneity and Plasticity
por: Strauss, Robert, et al.
Publicado: (2011)

Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11, and 14
por: Wang, Hongjie, et al.
Publicado: (2010)

Calcium Gluconate in Phosphate Buffered Saline Increases Gene Delivery with Adenovirus Type 5
por: Ahonen, Marko T., et al.
Publicado: (2010)

Incomplete but Infectious Vaccinia Virions Are Produced in the Absence of Oncolysis in Feline SCCF1 Cells
por: Parviainen, Suvi, et al.
Publicado: (2015)

Toxicological and bio-distribution profile of a GM-CSF-expressing, double-targeted, chimeric oncolytic adenovirus ONCOS-102 – Support for clinical studies on advanced cancer treatment
por: Kuryk, Lukasz, et al.
Publicado: (2017)

Immuno-Therapy with Anti-CTLA4 Antibodies in Tolerized and Non-Tolerized Mouse Tumor Models
por: Persson, Jonas, et al.
Publicado: (2011)

Optimized Mouse Model for the Imaging of Tumor Metastasis upon Experimental Therapy
por: Lavilla-Alonso, Sergio, et al.
Publicado: (2011)

Autocrine VEGF–VEGFR2–Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth
por: Hamerlik, Petra, et al.
Publicado: (2012)

Adenoviruses with an α(v)β integrin targeting moiety in the fiber shaft or the HI-loop increase tumor specificity without compromising antitumor efficacy in magnetic resonance imaging of colorectal cancer metastases
por: Lavilla-Alonso, Sergio, et al.
Publicado: (2010)

Portrait of a Leader in Immunotherapeutics: Oncolytic viruses for treatment of cancer
por: Hemminki, Akseli
Publicado: (2012)

Oncolytic Immunotherapy: Where Are We Clinically?
por: Hemminki, Akseli
Publicado: (2014)

Safety and biodistribution of a double-deleted oncolytic vaccinia virus encoding CD40 ligand in laboratory Beagles
por: Autio, Karoliina, et al.
Publicado: (2014)

Survival in colon and rectal cancers in Finland and Sweden through 50 years
por: Hemminki, Kari, et al.
Publicado: (2021)

Adenovirus-mediated intratumoral expression of immunostimulatory proteins in combination with systemic Treg inactivation induces tumor-destructive immune responses in mouse models
por: Ying, Liu, et al.
Publicado: (2011)

Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment
por: Hirvinen, Mari, et al.
Publicado: (2013)

Serotype Chimeric Human Adenoviruses for Cancer Gene Therapy
por: Ranki, Tuuli, et al.
Publicado: (2010)

Oncolytic adenovirus for treatment of malignant ascites
por: Hemminki, Akseli, et al.
Publicado: (2022)

Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden
por: Hemminki, Kari, et al.
Publicado: (2021)

Incidence trends in bladder and lung cancers between Denmark, Finland and Sweden may implicate oral tobacco (snuff/snus) as a possible risk factor
por: Hemminki, Kari, et al.
Publicado: (2021)

Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years
por: Hemminki, Kari, et al.
Publicado: (2022)

Long-term survival trends for primary liver and pancreatic cancers in the Nordic countries
por: Hemminki, Kari, et al.
Publicado: (2022)

Survival in gastric and esophageal cancers in the Nordic countries through a half century
por: Hemminki, Kari, et al.
Publicado: (2023)

Survival in Lung Cancer in the Nordic Countries Through A Half Century
por: Tichanek, Filip, et al.
Publicado: (2023)

Survival in melanoma in the nordic countries into the era of targeted and immunological therapies
por: Tichanek, Filip, et al.
Publicado: (2023)

Survival in Kidney and Bladder Cancers in Four Nordic Countries through a Half Century
por: Tichanek, Filip, et al.
Publicado: (2023)

Conditional Survival in Prostate Cancer in the Nordic Countries Elucidates the Timing of Improvements
por: Zitricky, Frantisek, et al.
Publicado: (2023)

Long-Term Periodic and Conditional Survival Trends in Prostate, Testicular, and Penile Cancers in the Nordic Countries, Marking Timing of Improvements
por: Tichanek, Filip, et al.
Publicado: (2023)

Survival, Incidence, and Mortality Trends in Female Cancers in the Nordic Countries
por: Tichanek, Filip, et al.
Publicado: (2023)

Causes of death in patients with extranodal cancer of unknown primary: searching for the primary site
por: Riihimäki, Matias, et al.
Publicado: (2014)

Patterns of metastasis in colon and rectal cancer
por: Riihimäki, Matias, et al.
Publicado: (2016)

Risk of other Cancers in Families with Melanoma: Novel Familial Links
por: Frank, Christoph, et al.
Publicado: (2017)

Familial Associations of Colorectal Cancer with Other Cancers
por: Yu, Hongyao, et al.
Publicado: (2017)

Oncolytic viruses for cancer immunotherapy
por: Hemminki, Otto, et al.
Publicado: (2020)

Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden
por: Hemminki, Kari, et al.
Publicado: (2021)

Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment
por: Hemminki, Kari, et al.
Publicado: (2022)

Conditional survival in breast cancer up to 10 years in the Nordic countries
por: Zitricky, Frantisek, et al.
Publicado: (2023)

Plasticity and intratumoural heterogeneity of cell surface antigen expression in breast cancer
por: Remšík, Ján, et al.
Publicado: (2018)

Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer
por: Riihimäki, Matias, et al.
Publicado: (2013)

Location of metastases in cancer of unknown primary are not random and signal familial clustering
por: Hemminki, Kari, et al.
Publicado: (2016)

Metastatic spread in patients with gastric cancer
por: Riihimäki, Matias, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5hnkqabdtpmq70qjnqahf7us1s